Table 2: Metabolic parameters of the study groups.

 

Control n: 31

Type 1 DM n: 64

Type 2 DM n: 67

p

Significant within group differences

Betatrophin(ng/l)

106.19 ± 59.07

322.73 ± 366.05

144.84 ± 124.50

0.000a

Type 1 DM >Controle

Type 1 DM >Type 2 DMe

C-peptide(ng/ml)

1.16 ± 0.69

0.56 ± 0.34

1.34 ± 0.78

0.000a

Type 1 DM <Controle

Type 2 DM >Type 1 DMe

GFR(ml/dak -1.73m2)

115.30 ± 25.31

111.07 ± 27.96

91.33 ± 41.66

0.000a

Type 2 DM <Controle

Type 2 DM <Type 1 DMe

Microalbuminuria

(mg/g)

38.69 ± 115.05

129.50 ± 318.09

139.55 ± 298.86

0.010a

Type 1 DM >Controle

Type 2 DM >Controle

Total C)(mg/dl)

202.55 ± 43.74

190.56 ± 51.46

211.27 ± 44.90

0.046b

Type 2 DM >Type 1 DMd

Triglyceride

(mg/dl)

135.77 ± 76.98

179.97 ± 194.20

196.45 ± 133.29

0.022a

Type 2 DM >Controle

HDL-C(mg/dl)

45.65 ± 10.02

45.95 ± 15.17

46.75 ± 16.08

0.895a

N/A

LDL-C(mg/dl)

122.81 ± 33.57

114.56 ± 35.38

131.46 ± 39.80

0.037b

Type 2 DM >Type 1 DMd

FBG(mg/dl)

84.58 ± 12.91

151.86 ± 57.33

162.17 ± 43.76

0.000a

Type 1 DM >Controle

Type 2 DM >Controle

Type 2 DM >Type 1 DMe

Insulin(qU/ml)

7.02 ± 1.19

4.48 ± 2.21

7.22 ± 3.04

0.000a

Type 1 DM <Controle

Type 2 DM >Type 1 DMe

Albumin(g/dl)

4.28 ± 0.26

4.23 ± 0.39

4.24 ± 0.33

0.961a

N/A

CRP(mg/dl)

0.67 ± 0.50

0.58 ± 0.43

0.81 ± 1.49

0.714a

N/A

HbA1c(%)

6.38 ± 1.09

8.71 ± 2.11

8.49 ± 2.02

0.000b

Type 2 DM > Controld

Type 1 DM > Controld

Kruskal Wallis H Test, b. One Way ANOVA Test, d. Tukey Test, e. Mann Whitney U Test, N/A: Not Applicable

C-peptide: 0.8-3.85 ng/ml, GFR>110 ml/dk/1.73m2, microalbuminuri: 30-300 mg/dl, T-cholesterol < 200mg/dl, triglyceride < 150 mg/dl, LDL-C < 130 mg/dl, HDL-C: 40-60 mg/dl, FBG: 70-95 mg/dl, insulin: 1.923 qU/ml, albumin: 3.5 g/dl, CRP: 0-5 mg/dl, HbA1c: 6.5 %